September 4, 2024
“…COMPASS Pathways (CMPS)… Morgan Stanley analyst Vikram Purohit, who covers the stock, sees CMPS as presenting a compelling risk-reward opportunity. He highlights the company’s leading clinical program… To this end, Purohit rates CMPS shares an Overweight (i.e. Buy), and his $23 price… Continue Reading…
August 12, 2024
“CervoMed (CRVO) The first Morgan Stanley pick we’ll look at is CervoMed, a clinical-stage medical research firm specializing in neurodegenerative diseases and conditions… Overall, the analyst expects positive clinical results and rates CRVO an Overweight (i.e., Buy). His $35 price… Continue Reading…
July 31, 2024
“…RegenXBio (RGNX) The first Goldman pick we’ll look at is RegenXBio, a gene therapy company specializing in single-dose treatments for severe diseases with few or no existing therapies…. Choi rates RGNX a Buy along with a $38 price target. This… Continue Reading…
May 13, 2024
“Auna S.A. (AUNA)… Cepeda’s views back up his Overweight (Buy) rating on the stock, and his $14 price-target points toward a robust 110% upside potential for the next 12 months. (To watch Cepeda’s track record, click here)… Contineum Therapeutics (CTNM)… Hung goes… Continue Reading…
March 15, 2024
“…Next up is the online insurance marketplace EverQuote. This company operates a platform that connects insurance buyers with insurance agents and covers multiple aspects of the industry… As more and more consumers, across the economy generally, turn to online and… Continue Reading…
September 13, 2022
“…“Our ’22/’23/’24 base case estimates are now 3%/13%/14% below consensus, respectively,” a team of Morgan Stanley analysts led by Mike Wilson write in a recent note to investors. “In our base case, 2023 now marks a modest earnings contraction (-3%… Continue Reading…
November 24, 2021
“”Labor market tightness will remain a challenge during the next few years. Investors should avoid stocks with high labor costs relative to EBIT [earnings before interest and taxes],” says David Kostin, Goldman Sachs chief U.S. equity strategist, in a new research… Continue Reading…
April 12, 2021
“Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist? Boeing (BA), Floor & Decor (FND), Target (TGT) Scotts Miracle-Gro (SMG) and the VanEck Vectors Semiconductor ETF… Continue Reading…
March 30, 2021
“Investment banks Credit Suisse and Nomura said they would incur significant losses after the U.S.-based hedge fund was forced into a fire sale of assets and defaulted on its margin calls. “The estimated amount of the claim against the client… Continue Reading…
December 21, 2020
“Lordstown Motors (RIDE)… Overall, RIDE shares get a Hold from the analyst consensus, reflecting Wall Street caution toward a new – and highly speculative – endeavor. The rating is derived from 4 recent reviews, evenly split between 2 Buys and 2… Continue Reading…
Recent Comments